1. Home
  2. OVBC vs ENTX Comparison

OVBC vs ENTX Comparison

Compare OVBC & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$38.89

Market Cap

163.3M

Sector

Finance

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.61

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVBC
ENTX
Founded
1872
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.3M
142.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
OVBC
ENTX
Price
$38.89
$1.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
15.0K
208.2K
Earning Date
01-27-2026
11-14-2025
Dividend Yield
2.35%
N/A
EPS Growth
22.03
N/A
EPS
3.01
N/A
Revenue
$64,211,000.00
$124,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.05
N/A
Revenue Growth
11.98
25.25
52 Week Low
$21.86
$1.50
52 Week High
$42.00
$3.22

Technical Indicators

Market Signals
Indicator
OVBC
ENTX
Relative Strength Index (RSI) 49.27 33.90
Support Level $38.59 $1.53
Resistance Level $40.90 $1.99
Average True Range (ATR) 0.94 0.19
MACD -0.31 -0.01
Stochastic Oscillator 39.29 13.79

Price Performance

Historical Comparison
OVBC
ENTX

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: